Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Freyschmidt-Paul

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
European Journal of Dermatology : EJD|July 19, 2001
Guess what! Atrichia with papular lesionsT Küster, R Happle, R Hoffmann, et al.
American Journal of Contact Dermatitis : Official Journal of the American Contact Dermatitis Society|March 13, 2001
Pitfalls of irritant patch testing using different test chamber sizesH Löffler, P Freyschmidt-Paul, I Effendy, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|October 6, 1998
[Neonatal lupus erythematosus and maternal HELLP syndrome: is there a pathogenetic link?]P Freyschmidt-Paul, C H Rieger, R Happle, et al.
European Journal of Dermatology : EJD|February 15, 2001
Genetic susceptibility and severity of alopecia areata in human and animal modelsK McElwee, P Freyschmidt-Paul, A Ziegler, et al.
European Journal of Dermatology : EJD|June 16, 2001
Hermansky-Pudlak syndromeA Krisp, R Hoffman, R Happle, et al.
Journal of Medical Primatology|May 23, 2007
Alopecia areata in a rhesus monkey (Macaca mulatta)B Beardi, F Wanert, M Zöller, et al.
Clinical and Experimental Immunology|March 11, 2004
Chronic delayed-type hypersensitivity reaction as a means to treat alopecia areataM Zöller, P Freyschmidt-Paul, M Vitacolonna, et al.
The Journal of Investigative Dermatology. Symposium Proceedings|January 13, 2006
The functional relevance of the type 1 cytokines IFN-gamma and IL-2 in alopecia areata of C3H/HeJ miceP Freyschmidt-Paul, M Zoller, K J McElwee, et al.
European Journal of Dermatology : EJD|September 11, 2004
Treatment of alopecia areata in the DEBR model using Cyclosporin A lipid vesiclesD D Verma, S Verma, K J McElwee, et al.
Current Pharmaceutical Design|April 20, 2001
Current and potential agents for the treatment of alopecia areataP Freyschmidt-Paul, R Hoffmann, E Levine, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
European Journal of Dermatology : EJD|July 19, 2001
Guess what! Atrichia with papular lesionsT Küster, R Happle, R Hoffmann, et al.
American Journal of Contact Dermatitis : Official Journal of the American Contact Dermatitis Society|March 13, 2001
Pitfalls of irritant patch testing using different test chamber sizesH Löffler, P Freyschmidt-Paul, I Effendy, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|October 6, 1998
[Neonatal lupus erythematosus and maternal HELLP syndrome: is there a pathogenetic link?]P Freyschmidt-Paul, C H Rieger, R Happle, et al.
European Journal of Dermatology : EJD|February 15, 2001
Genetic susceptibility and severity of alopecia areata in human and animal modelsK McElwee, P Freyschmidt-Paul, A Ziegler, et al.
European Journal of Dermatology : EJD|June 16, 2001
Hermansky-Pudlak syndromeA Krisp, R Hoffman, R Happle, et al.
Journal of Medical Primatology|May 23, 2007
Alopecia areata in a rhesus monkey (Macaca mulatta)B Beardi, F Wanert, M Zöller, et al.
Clinical and Experimental Immunology|March 11, 2004
Chronic delayed-type hypersensitivity reaction as a means to treat alopecia areataM Zöller, P Freyschmidt-Paul, M Vitacolonna, et al.
The Journal of Investigative Dermatology. Symposium Proceedings|January 13, 2006
The functional relevance of the type 1 cytokines IFN-gamma and IL-2 in alopecia areata of C3H/HeJ miceP Freyschmidt-Paul, M Zoller, K J McElwee, et al.
European Journal of Dermatology : EJD|September 11, 2004
Treatment of alopecia areata in the DEBR model using Cyclosporin A lipid vesiclesD D Verma, S Verma, K J McElwee, et al.
Current Pharmaceutical Design|April 20, 2001
Current and potential agents for the treatment of alopecia areataP Freyschmidt-Paul, R Hoffmann, E Levine, et al.
Pageof 3